Skip to main content
Smart Investors Daily
Nuo Therapeutics, Inc. logo

OTC · AURX

Nuo Therapeutics, Inc.

Healthcare · Biotechnology

$1.07

Up+$0.00 (+0.00%)

Updated Nov 10, 2026, 8:29 PM

SID Score

2.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
100.96M
P/E ratio
-41.08
Dividend yield
0.00%
52-week range
$0.77 – $3.23
Volume
1.5K
Avg. volume
3.73K

Price performance · AURX

AURX price history

1M range · 12 trading sessions · Daily adjusted prices

Prices through Nov 5, 2026

AURX closed at $1.07 after 12 trading sessions, down 17.69% for the selected period.

Last close
$1.07
Period change
-17.69%
Period low
$1.07
Period high
$1.31
Daily close
View OHLC price history
AURX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 5, 2026$1.20$1.20$1.07$1.071.5K
Nov 4, 2026$1.25$1.2575$1.25$1.2575200
Nov 3, 2026$1.27$1.27$1.27$1.271K
Oct 30, 2026$1.28$1.28$1.27$1.276.16K
Oct 23, 2026$1.30$1.30$1.29$1.3025.21K
Oct 22, 2026$1.30$1.30$1.30$1.30100
Oct 21, 2026$1.25$1.30$1.25$1.3010K
Oct 20, 2026$1.26$1.26$1.25$1.251.65K
Oct 19, 2026$1.28$1.30$1.25$1.2669.87K
Oct 15, 2026$1.30$1.30$1.26$1.3027.7K
Oct 14, 2026$1.31$1.31$1.31$1.31357
Oct 13, 2026$1.303$1.303$1.30$1.30276

Latest AURX news

The latest Smart Investors Daily articles mentioning AURX.

AURX research

Overview

Company profile and research snapshot.

Company profile

NUO THERAPEUTICS INC NEW

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
AURX recent ratings
DateFirmRatingTarget
Dec 16, 2025Roth CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.